Literature DB >> 27490631

Looking to the future following 10 years of induced pluripotent stem cell technologies.

Mo Li1,1, Juan Carlos Izpisua Belmonte1.   

Abstract

The development of induced pluripotent stem cells (iPSCs) has fundamentally changed our view on developmental cell-fate determination and led to a cascade of technological innovations in regenerative medicine. Here we provide an overview of the progress in the field over the past decade, as well as our perspective on future directions and clinical implications of iPSC technology.

Mesh：

Year:  2016        PMID： 27490631     DOI： 10.1038/nprot.2016.108

Source DB:  PubMed          Journal:  Nat Protoc        ISSN： 1750-2799            Impact factor:   13.491


  79 in total

Review 1.  Guidelines and techniques for the generation of induced pluripotent stem cells.

Authors:  Nimet Maherali; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

2.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

3.  No factor left behind: generation of transgene-free induced pluripotent stem cells.

Authors:  Mo Li; Juan Carlos Izpisua Belmonte
Journal:  Am J Stem Cells       Date:  2011-09-19

4.  GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts.

Authors:  H Kulessa; J Frampton; T Graf
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

5.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

6.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  iPS cells produce viable mice through tetraploid complementation.

Authors:  Xiao-yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-long Guo; Qing-wen Ma; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Nature       Date:  2009-09-03       Impact factor: 49.962

8.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

9.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

10.  Modelling human development and disease in pluripotent stem-cell-derived gastric organoids.

Authors:  Kyle W McCracken; Emily M Catá; Calyn M Crawford; Katie L Sinagoga; Michael Schumacher; Briana E Rockich; Yu-Hwai Tsai; Christopher N Mayhew; Jason R Spence; Yana Zavros; James M Wells
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962
View more
  14 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 2.  Ground rules of the pluripotency gene regulatory network.

Authors:  Mo Li; Juan Carlos Izpisua Belmonte
Journal:  Nat Rev Genet       Date:  2017-01-03       Impact factor: 53.242

3.  Transient exposure to miR-203 enhances the differentiation capacity of established pluripotent stem cells.

Authors:  María Salazar-Roa; Marianna Trakala; Mónica Álvarez-Fernández; Fátima Valdés-Mora; Cuiqing Zhong; Jaime Muñoz; Yang Yu; Timothy J Peters; Osvaldo Graña-Castro; Rosa Serrano; Elisabet Zapatero-Solana; María Abad; María José Bueno; Marta Gómez de Cedrón; José Fernández-Piqueras; Manuel Serrano; María A Blasco; Da-Zhi Wang; Susan J Clark; Juan Carlos Izpisua-Belmonte; Sagrario Ortega; Marcos Malumbres
Journal:  EMBO J       Date:  2020-07-02       Impact factor: 11.598

4.  Taiji-reprogram: a framework to uncover cell-type specific regulators and predict cellular reprogramming cocktails.

Authors:  Jun Wang; Cong Liu; Yue Chen; Wei Wang
Journal:  NAR Genom Bioinform       Date:  2021-11-08

5.  Wiskott-Aldrich syndrome protein forms nuclear condensates and regulates alternative splicing.

Authors:  Baolei Yuan; Xuan Zhou; Keiichiro Suzuki; Gerardo Ramos-Mandujano; Mengge Wang; Muhammad Tehseen; Lorena V Cortés-Medina; James J Moresco; Sarah Dunn; Reyna Hernandez-Benitez; Tomoaki Hishida; Na Young Kim; Manal M Andijani; Chongwei Bi; Manching Ku; Yuta Takahashi; Jinna Xu; Jinsong Qiu; Ling Huang; Christopher Benner; Emi Aizawa; Jing Qu; Guang-Hui Liu; Zhongwei Li; Fei Yi; Yanal Ghosheh; Changwei Shao; Maxim Shokhirev; Patrizia Comoli; Francesco Frassoni; John R Yates; Xiang-Dong Fu; Concepcion Rodriguez Esteban; Samir Hamdan; Juan Carlos Izpisua Belmonte; Mo Li
Journal:  Nat Commun       Date:  2022-06-25       Impact factor: 17.694

Review 6.  Induced pluripotent stem cells as a tool for comparative physiology: lessons from the thirteen-lined ground squirrel.

Authors:  Jingxing Ou; Sarah Rosa; Luke E Berchowitz; Wei Li
Journal:  J Exp Biol       Date:  2019-10-04       Impact factor: 3.312

Review 7.  Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease.

Authors:  Natalia Jiménez-Moreno; Petros Stathakos; Maeve A Caldwell; Jon D Lane
Journal:  Cells       Date:  2017-08-11       Impact factor: 6.600

8.  Modeling the Role of Wnt Signaling in Human and Drosophila Stem Cells.

Authors:  Prameet Kaur; Helen Jingshu Jin; Jay B Lusk; Nicholas S Tolwinski
Journal:  Genes (Basel)       Date:  2018-02-16       Impact factor: 4.096

9.  AAVvector-mediated in vivo reprogramming into pluripotency.

Authors:  Elena Senís; Lluc Mosteiro; Stefan Wilkening; Ellen Wiedtke; Ali Nowrouzi; Saira Afzal; Raffaele Fronza; Henrik Landerer; Maria Abad; Dominik Niopek; Manfred Schmidt; Manuel Serrano; Dirk Grimm
Journal:  Nat Commun       Date:  2018-07-09       Impact factor: 14.919

10.  Human pancreatic islet-derived extracellular vesicles modulate insulin expression in 3D-differentiating iPSC clusters.

Authors:  Diana Ribeiro; Eva-Marie Andersson; Nikki Heath; Anette Persson-Kry; Richard Collins; Ryan Hicks; Niek Dekker; Anna Forslöw
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.